Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.
Eligibility
Sex
ALL
Min age
18 Years
Max age
110 Years
Healthy volunteers
No
Inclusion Criteria:
* Age above 18 years and consentable
* Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis
* Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision
* Written informed consent
Exclusion Criteria:
* Patient's inability to fully cooperate with the protocol
Primary outcome measure(s)
Long-term mortality — 5 years Long-term mortality
Trial sites (1)
Facility
City
Region
Status
Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
Munich
Bavaria
Recruiting
More Deutsches Herzzentrum Muenchen trials in Germany
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.